Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?

doi:10.3748/wjg.v22.i27.6114

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9091)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

715

WORD

269

HTML

4602

Figures (1-1)

148

Tables (1-2)

165

Sum=5899

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

430

Download

431

Sum=861

Publishing Process of This Article

Item

Count

Browse

1066

Download

1265

Sum=2331

Jul 21, 2016 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jul 21, 2016; 22(27): 6114-6126
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6114

Open in New Tab Full Size Figure Download Figure

Figure 1 Targeted therapies and signaling pathways in hepatocellular carcinoma.

Citation: Montella L, Palmieri G, Addeo R, Del Prete S. Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? World J Gastroenterol 2016; 22(27): 6114-6126
URL: https://www.wjgnet.com/1007-9327/full/v22/i27/6114.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i27.6114